Phosphatidylserine-Containing Liposomes: Potential Pharmacological Interventions Against Inflammatory and Immune Diseases Through the Production of Prostaglandin E2 After Uptake by Myeloid Derived Phagocytes

Phosphatidylserine-Containing Liposomes Inhibit the Differentiation of Osteoclasts and Trabecular Bone Loss

(2010) Z. Wu et al.   JOURNAL OF IMMUNOLOGY

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2

(2009) G. M. Spaggiari et al.   BLOOD

Effects of prostaglandin E2 on bone in mice in vivo

(2009) Qi Gao et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

The Mechanism of Anti-Inflammatory Effects of Prostaglandin E2 Receptor 4 Activation in Murine Cardiac Transplantation

(2009) Masahito Ogawa et al.   TRANSPLANTATION

Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice

(2008) Byeong Suk Chae et al.   ARCHIVES OF PHARMACAL RESEARCH

Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats

(2008) X.Y. Tian et al.   BONE

Prostaglandin E2 inhibits tumor necrosis factor-alpha RNA through PKA type I

(2007) Jennifer B. Stafford et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS